Treatments for colorectal liver metastases: A new focus on a familiar concept.

[1]  V. Gebski,et al.  SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Petr Vávra,et al.  Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go? , 2015, World journal of gastroenterology.

[3]  J. Ledermann,et al.  O-018Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Long-term survival results of a randomised phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC) , 2015 .

[4]  M. Gonen,et al.  Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. , 2015, American journal of surgery.

[5]  M. Buyse,et al.  Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial†. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  J. Li,et al.  COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer , 2015, BMC Cancer.

[7]  L. Jing,et al.  The effect of radiofrequency ablation vs. liver resection on survival outcome of colorectal liver metastases (CRLM): a meta-analysis. , 2015, Hepato-gastroenterology.

[8]  S. Solomon,et al.  Ablative and catheter-directed therapies for colorectal liver and lung metastases. , 2015, Hematology/oncology clinics of North America.

[9]  M. Gönen,et al.  Hepatic Parenchymal Preservation Surgery: Decreasing Morbidity and Mortality Rates in 4,152 Resections for Malignancy , 2014, Journal of the American College of Surgeons.

[10]  C. Scoggins,et al.  Small Versus Large-Sized Drug-Eluting Beads (DEBIRI) for the Treatment of Hepatic Colorectal Metastases: A Propensity Score Matching Analysis , 2015, CardioVascular and Interventional Radiology.

[11]  T. Vogl,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Journal of vascular and interventional radiology : JVIR.

[12]  E. Van Cutsem,et al.  Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  Karin Nielsen,et al.  Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. , 2014, Journal of vascular and interventional radiology : JVIR.

[14]  M. Bloomston,et al.  Microwave Ablation for Hepatic Malignancies: A Multiinstitutional Analysis , 2014, Annals of surgery.

[15]  K. Boudjema,et al.  Disease-Free Survival after Simultaneous or Delayed Resection of Synchronous Colorectal Liver Metastasis and Primary Cancer. , 2014, Hepato-gastroenterology.

[16]  H. Amthauer,et al.  Left‐liver hypertrophy after therapeutic right‐liver radioembolization is substantial but less than after portal vein embolization , 2014, Hepatology.

[17]  T. Hickish,et al.  Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial. , 2014, The Lancet. Oncology.

[18]  J. Ledermann,et al.  Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. , 2014, European journal of cancer.

[19]  R. Lencioni,et al.  Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations. , 2014, Journal of vascular and interventional radiology : JVIR.

[20]  I. Nagtegaal,et al.  Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  P. Karanicolas,et al.  Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era. , 2013, Current oncology.

[22]  M. Abecassis,et al.  Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. , 2013, Journal of hepatology.

[23]  R. Parks,et al.  Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. , 2013, The Lancet. Oncology.

[24]  B. Glimelius,et al.  Adjuvant chemotherapy , 2013, EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.].

[25]  M. Gonen,et al.  Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. , 2013, JAMA surgery.

[26]  M. Gonen,et al.  Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution , 2013, Annals of Surgical Oncology.

[27]  E. Abdalla,et al.  Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. , 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[28]  V. Catalano,et al.  Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. , 2012, Anticancer research.

[29]  H. Amthauer,et al.  Hepatic Toxicity After Radioembolization of the Liver Using 90Y-Microspheres: Sequential Lobar Versus Whole Liver Approach , 2012, CardioVascular and Interventional Radiology.

[30]  M. Gönen,et al.  Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer , 2011, Annals of surgery.

[31]  G. Benea,et al.  Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study. , 2011, Anticancer research.

[32]  A. Koong,et al.  Stereotactic body radiotherapy for colorectal liver metastases , 2011, Cancer.

[33]  G. Fiorentini.  A new tool to enhance the efficacy of chemoembolization to treat primary and metastatic hepatic tumors , 2011, Expert opinion on drug delivery.

[34]  M. D'Angelica,et al.  Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  D. Fraker,et al.  Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol , 2011, Cancer.

[36]  P. Weatherall,et al.  Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy in Patients With Hepatic Metastases , 2011, Annals of Surgical Oncology.

[37]  E. Van Cutsem,et al.  Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  F. Izzo,et al.  Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases , 2010, British Journal of Cancer.

[39]  T. de Baère,et al.  Prolonged Survival of Initially Unresectable Hepatic Colorectal Cancer Patients Treated With Hepatic Arterial Infusion of Oxaliplatin Followed by Radical Surgery of Metastases , 2010, Annals of surgery.

[40]  D. Nagorney,et al.  Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Yuman Fong,et al.  American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  J. Weitz,et al.  Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. , 2010, The Lancet. Oncology.

[43]  G. M. Briggs,et al.  Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  L. Schwartz,et al.  Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  M. D'Angelica,et al.  Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[46]  K. Eichler,et al.  Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. , 2009, Radiology.

[47]  M. A. Bosch,et al.  Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis , 2009, European Radiology.

[48]  L. Rubbia‐Brandt,et al.  ‘Liver First’ Approach in the Treatment of Colorectal Cancer with Synchronous Liver Metastases , 2009, Digestive Surgery.

[49]  Guy Marchal,et al.  Radiofrequency Ablation versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial? , 2009, Digestive Surgery.

[50]  M. Choti,et al.  Trends in Nontherapeutic Laparotomy Rates in Patients Undergoing Surgical Therapy for Hepatic Colorectal Metastases , 2009, Annals of Surgical Oncology.

[51]  W. Lees,et al.  Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation , 2009, European Radiology.

[52]  I. B. Borel Rinkes,et al.  RADIOFREQUENCY ABLATION (RFA) COMBINED WITH CHEMOTHERAPY FOR UNRESECTABLE COLORECTAL LIVER METASTASES (CRC LM): INTERIM RESULTS OF A RANDOMISED PHASE II STUDY OF THE EORTC-NCRI CCSG-ALM INTERGROUP 40004 (CLOCC) , 2008 .

[53]  S. Mocellin,et al.  Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  Yuman Fong,et al.  Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  R. Parks,et al.  Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. , 2007, Journal of the American College of Surgeons.

[56]  P. Gibbs,et al.  Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  T. Pawlik,et al.  Debunking dogma: Surgery for four or more colorectal liver metastases is justified , 2006, Journal of Gastrointestinal Surgery.

[58]  A. Lewis,et al.  Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[59]  M. Ducreux,et al.  Hepatic Arterial Infusion of Oxaliplatin and Intravenous LV5FU2 in Unresectable Liver Metastases from Colorectal Cancer after Systemic Chemotherapy Failure , 2007, Annals of Surgical Oncology.

[60]  J. Bosset,et al.  Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  M. Choti,et al.  Selection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus Statement , 2006, Annals of Surgical Oncology.

[62]  P. Gibbs,et al.  A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy , 2005, BMC Cancer.

[63]  L. Schwartz,et al.  Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  Agnès Laplanche,et al.  Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  E. Berber,et al.  Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  M. Gonen,et al.  Hepatic arterial infusion after liver resection. , 2005, The New England journal of medicine.

[67]  F. Lévi,et al.  Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases? , 2004, Annals of surgery.

[68]  G. van Hazel,et al.  Randomised phase 2 trial of SIR‐Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer , 2004, Journal of surgical oncology.

[69]  Bernard Paule,et al.  Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.

[70]  F. Orsi,et al.  Hepatic intra-arterial chemotherapy using a percutaneous catheter in pretreated patients with metastatic colorectal carcinoma. , 2003, Anticancer research.

[71]  M. Gonen,et al.  Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[72]  D. Kerr,et al.  Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial , 2003, The Lancet.

[73]  S. Mulier,et al.  Complications of radiofrequency coagulation of liver tumours , 2002, The British journal of surgery.

[74]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[75]  E. Wilkinson.  Cancer Research UK , 2002 .

[76]  S. Lipsitz,et al.  Abstracts reprinted from Journal of Clinical Oncology , 2002, Annals of Surgical Oncology.

[77]  H. Kindler,et al.  Metastatic colorectal cancer , 2001, Current treatment options in oncology.

[78]  Luigi Solbiati,et al.  Radiofrequency thermal ablation of hepatic metastases. , 2001, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[79]  L. Schwartz,et al.  Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  L Solbiati,et al.  Radiofrequency thermal ablation of hepatic metastases. , 2001, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[81]  C. Wilson,et al.  Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  Takashi Shibata,et al.  Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma , 2000, Cancer.

[83]  N. Kikkawa,et al.  Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases , 2000, Cancer.

[84]  M. Lorenz,et al.  Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[85]  L H Blumgart,et al.  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. , 1999, The New England journal of medicine.

[86]  J. Scheele,et al.  Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases , 1999, Langenbeck's Archives of Surgery.

[87]  W. Bechstein,et al.  Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen) , 1998, Annals of surgery.

[88]  A. Benson,et al.  Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature , 1998, Cancer.

[89]  L. Spence,et al.  Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma , 1997, Diseases of the colon and rectum.

[90]  J. Parissis,et al.  Resection versus resection combined with adjuvant pre- and post-operative chemotherapy--immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. , 1995, Hepato-gastroenterology.

[91]  C. Brown,et al.  Colorectal metastases to the liver: selective chemoembolization. , 1993, Radiology.

[92]  H. Kuga,et al.  Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. , 1991, Cancer research.

[93]  L. R. Hill,et al.  A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[94]  P D Schneider,et al.  A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. , 1987, Annals of surgery.

[95]  N. Geller,et al.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. , 1987, Annals of internal medicine.

[96]  Ensminger Wd,et al.  Clinical pharmacology of hepatic arterial chemotherapy. , 1983 .

[97]  W. Ensminger,et al.  Clinical pharmacology of hepatic arterial chemotherapy. , 1983, Seminars in oncology.